Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Systemic immunomodulatory therapies are the principal means of managing non-infectious uveitis. This review aims to explore the current landscape of systemic uveitis treatments, including biologic therapies and the advent of biosimilar therapies.

Original publication

DOI

10.1007/s40123-017-0115-5

Type

Journal article

Journal

Ophthalmol Ther

Publication Date

30/11/2017

Keywords

Biologics, Biosimilars, Interferon, Interleukins, Non-infectious uveitis, TNFα inhibitors